MECP2 duplication syndrome in both genders

Brain and Development

Volumn 35, Issue 5, 2013, Pages 411-419

  Shimada, Shino ^a   Okamoto, Nobuhiko ^b   Ito, Masahiro ^c   Arai, Yasuhiro ^d   Momosaki, Ken ^e   Togawa, Masami ^e   Maegaki, Yoshihiro ^e   Sugawara, Midori ^a   Shimojima, Keiko ^a   Osawa, Makiko ^a   Yamamoto, Toshiyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^d Tokyo Metropolitan Coll   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

Author keywords

Chromosomal microarray testing; MECP2 duplication; X chromosome inactivation (XCI); Xq28

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CHROMOSOME ABERRATION; CHROMOSOME XP; CHROMOSOME XQ; COPY NUMBER VARIATION; ELECTROENCEPHALOGRAM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DUPLICATION; GENE LOCUS; HUMAN; INFANT; MALE; MENTAL DEFICIENCY; METHYL CPG BINDING PROTEIN 2 DUPLICATION SYNDROME; PHENOTYPE; PRESCHOOL CHILD; SEX DIFFERENCE; X CHROMOSOME INACTIVATION;

ADOLESCENT; BRAIN; CHILD, PRESCHOOL; CHROMOSOME MAPPING; FEMALE; GENE DUPLICATION; HUMANS; INTELLECTUAL DISABILITY; MAGNETIC RESONANCE IMAGING; MALE; MENTAL RETARDATION, X-LINKED; METHYL-CPG-BINDING PROTEIN 2; PHENOTYPE; X CHROMOSOME INACTIVATION; YOUNG ADULT;

EID: 84875908942     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.07.010     Document Type: Article

References (26)

1. Shaffer L.G., Bejjani B.A., Torchia B., Kirkpatrick S., Coppinger J., Ballif B.C. The identification of microdeletion syndromes and other chromosome abnormalities: cytogenetic methods of the past, new technologies for the future. Am J Med Genet C Semin Med Genet 2007, 145:335-345.
2. Shao L., Shaw C.A., Lu X.Y., Sahoo T., Bacino C.A., Lalani S.R., et al. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 cases. Am J Med Genet A 2008, 146A:2242-2251.
3. Shimojima K., Inoue T., Hoshino A., Kakiuchi S., Watanabe Y., Sasaki M., et al. Comprehensive genetic analyses of PLP1 in patients with Pelizaeus-Merzbacher disease applied by array-CGH and fiber-FISH analyses identified new mutations and variable sizes of duplications. Brain Dev 2010, 32:171-179.
4. Shimojima K., Komoike Y., Tohyama J., Takahashi S., Páez M.T., Nakagawa E., et al. TULIP1 (RALGAPA1) haploinsufficiency with brain development delay. Genomics 2009, 94:414-422.
5. Shimojima K., Okamoto N., Inazu T., Yamamoto T. Tandem configurations of variably duplicated segments of 22q11.2 confirmed by fiber-FISH analysis. J Hum Genet 2011, 56:810-812.
6. Hickey T., Chandy A., Norman R.J. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:161-165.
7. Gonzales M.L., LaSalle J.M. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 2010, 12:127-134.
8. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
9. Topçu M., Akyerli C., Sayi A., Törüner G.A., Koçoĝlu S.R., Cimbiş M., et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002, 10:77-81.
10. Budisteanu M., Papuc S.M., Tutulan-Cunita A., Budisteanu B., Arghir A. Novel clinical finding in MECP2 duplication syndrome. Eur Child Adolesc Psychiatry 2011, 20:373-375.
11. Van Esch H., Bauters M., Ignatius J., Jansen M., Raynaud M., Hollanders K., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005, 77:442-453.
12. del Gaudio D., Fang P., Scaglia F., Ward P.A., Craigen W.J., Glaze D.G., et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 2006, 8:784-792.
13. Friez M.J., Jones J.R., Clarkson K., Lubs H., Abuelo D., Bier J.A.B., et al. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 2006, 118:e1687-e1695.
14. Smyk M., Obersztyn E., Nowakowska B., Nawara M., Cheung S.W., Mazurczak T., et al. Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:799-806.
15. Lugtenberg D., Kleefstra T., Oudakker A.R., Nillesen W.M., Yntema H.G., Tzschach A., et al. Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathy. Eur J Hum Genet 2009, 17:444-453.
16. Ramocki M.B., Tavyev Y.J., Peters S.U. The MECP2 duplication syndrome. Am J Med Genet A 2010, 152A:1079-1088.
17. Collins A.L., Levenson J.M., Vilaythong A.P., Richman R., Armstrong D.L., Noebels J.L., et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 2004, 13:2679-2689.
18. Alvarez-Saavedra M., Carrasco L., Sura-Trueba S., Aiello V.D., Walz K., Neto J.X., et al. Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development. Hum Mol Genet 2010, 19:2177-2190.
19. Bauters M., Van Esch H., Friez M.J., Boespflug-Tanguy O., Zenker M., Vianna-Morgante A.M., et al. Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res 2008, 18:847-858.
20. Carvalho C.M.B., Zhang F., Liu P., Patel A., Sahoo T., Bacino C.A., et al. Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet 2009, 18:2188-2203.
21. Makrythanasis P., Moix I., Gimelli S., Fluss J., Aliferis K., Antonarakis S.E., et al. De novo duplication of MECP2 in a girl with mental retardation and no obvious dysmorphic features. Clin Genet 2010, 78:175-180.
22. Grasshoff U., Bonin M., Goehring I., Ekici A., Dufke A., Cremer K., et al. De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation. Eur J Hum Genet 2011, 19:507-512.
23. Mayo S., Monfort S., Roselló M., Orellana C., Oltra S., Armstrong J., et al. De novo interstitial triplication of MECP2 in a girl with neurodevelopmental disorder and random X chromosome inactivation. Cytogenet Genome Res 2011, 135:93-101.
24. Badens C., Martini N., Courrier S., DesPortes V., Touraine R., Levy N., et al. ATRX syndrome in a girl with a heterozygous mutation in the ATRX Zn finger domain and a totally skewed X-inactivation pattern. Am J Med Genet A 2006, 140A:2212-2215.
25. Reardon W., Donoghue V., Murphy A.M., King M.D., Mayne P.D., Horn N., et al. Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr 2010, 169:941-949.
26. Echenne B., Roubertie A., Lugtenberg D., Kleefstra T., Hamel B.C.J., Van Bokhoven H., et al. Neurologic aspects of MECP2 gene duplication in male patients. Pediatr Neurol 2009, 41:187-191.